Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EML3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
WASIR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MINCR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATPAF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFRC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IBA57-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGPS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDE1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100505938 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ST20-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLEC4E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CUX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOSPD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00957 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KREMEN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTRF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAPGEF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on